Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCLA and Univ. of Utah researchers identify how a hormone regulates iron

29.10.2004


Findings may lead to treatments for hemochromatosis and anemia of chronic disease

A new UCLA and University of Utah study found how a hormone called hepcidin regulates the iron uptake from the diet and its distribution in the body. The study may help develop future treatments for chronic anemia and for diseases of iron overload, such as hemochromatosis. Published online in the journal Science this week, researchers discovered that the hormone hepcidin controls ferroportin, an iron-transporting molecule on the surface of specific cells that contain iron. Hepcidin signals ferroportin not to release iron into the blood stream.

Researchers realized that if there isn’t enough hepcidin to regulate ferroportin, too much iron is taken up from the digestive system into the body, which can lead to hemochromatosis, a major genetic disorder affecting about a million people in the United States. "For the first time we understand what happens in the disease hemochromatosis," said Dr. Tomas Ganz, Ph.D., M.D., one of the study’s principal investigators and professor of medicine and pathology at the David Geffen School of Medicine at UCLA. "We knew that ferroportin is necessary to help release iron into the bloodstream, but didn’t know that hepcidin directly regulates this activity."



Ganz adds that too much hepcidin present in the body -- which can occur in patients with infections or with inflammatory diseases such as rheumatoid arthritis or inflammatory bowel disease -- often results in not enough iron released into the blood stream causing chronic anemia. "We have defined how the hormone hepcidin regulates the accumulation of iron by the body," says Jerry Kaplan, Ph.D., one of the study’s principal authors and a professor of pathology and assistant vice president for basic science at the University of Utah Health Sciences Center. "This has implications for understanding both diseases that are caused by not enough iron and diseases that are caused by too much iron."

In a cell culture, researchers added hepcidin to cells and found that hepcidin attaches to ferroportin and causes ferroportin to be swallowed and destroyed by the cells. Without ferroportin on the surface to release the iron, the mineral remains trapped inside the cell. "Our findings may lead to new interventions for specific diseases," said Dr. Elizabeta Nemeth, the study’s first author and assistant research professor, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA. "Our next step will be to look more closely at molecular interactions of hepcidin and ferroportin in order to be able to develop treatment drugs."

Nemeth says that a form of hepcidin may be developed that people with hemochromatosis could inject to help reduce the amount of iron taken up by the body – similar to the use of insulin to control the amount of sugar in the body. For patients with anemia associated with too much hepcidin, Ganz adds that development of drugs to block hepcidin from binding to ferroportin might help release more iron into the body.

Hemochromatosis is the most common genetic disease in the United States according to the Centers for Disease Control. One in 100-200 people have a double mutation of a gene that puts them at risk for developing hemochromatosis, which causes an accumulation of excess iron in body tissues. Anemia of chronic disease is second only to iron-deficiency as a cause of anemia worldwide.

The National Institutes of Health funded the study. Other authors include: Marie S. Tuttle, Julie Powelson, Michael B. Vaughn and Diane McVey Ward from the Department of Pathology, School of Medicine, University of Utah; and Adriana Donovan, Department of Hematology, Children’s Hospital, Boston, MA.

Rachel Champeau | EurekAlert!
Further information:
http://www.ucla.edu

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Getting electrons to move in a semiconductor

25.04.2018 | Physics and Astronomy

Reconstructing what makes us tick

25.04.2018 | Physics and Astronomy

Cheap 3-D printer can produce self-folding materials

25.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>